Jennifer Fisher Wilson
CME Objective: To review current evidence for diagnosis, treatment, and practice improvement of stable ischemic heart disease.
Funding Source: American College of Physicians.
Disclosures: Ms. Wilson, ACP Contributing Author, has disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M13-2656.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that she has no financial relationships or interests to disclose. Darren B. Taichman, MD, PhD, Executive Deputy Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Pfizer.
With the assistance of additional physician writers, Annals of Internal Medicine editors develop In the Clinic using resources of the American College of Physicians, including ACP Smart Medicine and MKSAP (Medical Knowledge and Self-Assessment Program).
Wilson JF. Stable Ischemic Heart Disease. Ann Intern Med. 2014;160:ITC1–1. doi: https://doi.org/10.7326/0003-4819-160-1-201401070-01001
Download citation file:
© 2019
Published: Ann Intern Med. 2014;160(1):ITC1-1.
DOI: 10.7326/0003-4819-160-1-201401070-01001
Cardiology, Coronary Heart Disease.
Results provided by: